Ronald Caldwell, MD
Rheumatology · Hickory, NCNPI 1982656567
Payments from drug & device makers
Across 457 payments — averaging $50.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$9K
- Eli Lilly$6K
- Amgen$2K
- AbbVie$1K
- Johnson & Johnson$732
- UCB, Inc.$577
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $8,650 |
| Eli Lilly | 1 | $6,000 |
| Amgen(2 entities) | 113 | $1,955 |
| AbbVie | 68 | $1,094 |
| Johnson & Johnson(2 entities) | 32 | $732 |
| UCB, Inc. | 33 | $577 |
| Novartis | 29 | $575 |
| Pfizer | 35 | $511 |
| AstraZeneca(2 entities) | 25 | $444 |
| Lilly USA, LLC | 19 | $305 |
| E.r. Squibb & Sons, L.L.C. | 12 | $277 |
| GSK | 16 | $262 |
| Organon | 9 | $204 |
| Sanofi | 8 | $200 |
| Aurinia Pharma U.S., Inc. | 7 | $134 |
| Mallinckrodt Hospital Products Inc. | 5 | $118 |
| Boehringer Ingelheim | 6 | $114 |
| Genentech USA, Inc. | 6 | $108 |
| ANI Pharmaceuticals, Inc. | 5 | $91 |
| Radius Health, Inc. | 4 | $88 |
| Sandoz | 3 | $74 |
| Sobi, Inc | 3 | $69 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
| Scilex Pharmaceuticals Inc. | 2 | $49 |
| Mallinckrodt Enterprises LLC | 2 | $44 |
| Antares Pharma, Inc. | 2 | $32 |
| Merck | 2 | $26 |
| Boston Scientific | 1 | $23 |
| Octapharma USA, Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
How this compares
$22,911 in reported general payments places this provider in the 75th percentile of 210 rheumatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Hickory
- Dayton PayneHickory$919K
- Laura SchanbergDurham$6.9M
- Rakesh PatelSalisbury$4M
- Jane BoxCharlotte$3.9M
- Gordon LamCharlotte$3.5M
- David SnowDelco$3.4M
- Alireza NamiCharlotte$3.1M
- Tauseef SyedGreensboro$1.7M
- Michael HershfieldDurham$1.5M
- Ralph SnydermanDurham$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.